Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer

Rong Wu, Zhichao Xi, Mengfan Liu, Hangui Ren, Rongchen Dai, Xue Jiang, Wan Najbah Nik Nabil, Yalin Wang, Jiling Feng, Qiong Chai, Qihan Dong, Hong‐Xi XuChinese 2023 · DOI

TL;DR

This study investigates the anti-cancer potential of Pulsatilla Decoction (PD), a traditional Chinese medicine, against pancreatic cancer (PAC). Researchers identified that the herb Pulsatillae chinensis (BTW) within PD, and specifically its isolated compound β-peltatin, are responsible for inhibiting PAC cell growth by inducing cell cycle arrest at the G2/M phase and promoting apoptosis. This work highlights a promising natural compound for further development as a PAC therapeutic.

What Problem Does This Paper Address?

Pancreatic cancer (PAC) is a particularly deadly malignancy with a low survival rate, and current treatments have limited efficacy, often leading to recurrence. Traditional Chinese Medicine (TCM) offers a rich source of potential anti-cancer agents, but understanding the specific bioactive components and their mechanisms of action within complex herbal formulas like Pulsatilla Decoction (PD) has been a challenge. This paper aims to dissect PD's anti-PAC effects, identify the key contributing herb and its active compound, and elucidate the molecular mechanisms behind its anti-cancer activity.

Methods

The researchers employed a multi-faceted approach:

  • High-Performance Liquid Chromatography (HPLC): Used for quality control of the PD extract and to identify its chemical composition.
  • Cell Viability Assays (CCK-8): Standard method to quantify the effect of PD, its components, and individual herbs on cancer cell proliferation.
  • Flow Cytometry (Propidium Iodide staining): Utilized to analyze cell cycle distribution and identify cell cycle arrest points.
  • Annexin V-FITC/PI Double Staining: A common technique to detect and quantify apoptotic cells.
  • Immunoblotting (Western Blot): Employed to examine the expression levels of key proteins involved in cell cycle regulation (e.g., CDK1, Cyclin B1, CDC25C) and apoptosis (e.g., PARP, Caspase 3, Caspase 9, Bcl-2).
  • In Vivo Xenograft Model: A mouse model was used to evaluate the anti-tumor efficacy and toxicity of β-peltatin and its isomer podophyllotoxin in a more complex biological system.
  • Histopathology (H&E staining) and Immunohistochemistry: Used to assess tumor morphology and the expression of proliferation markers (Ki-67) and apoptosis markers in tumor tissues from the animal study.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • PD's Potent Anti-PAC Activity: The study confirmed that Pulsatilla Decoction (PD) exhibits significant cytotoxicity against pancreatic cancer cells.
  • Identifying the Key Herb: Through systematic disassembly of PD, Pulsatillae chinensis (BTW) was identified as the primary herb responsible for the anti-PAC effect.
  • β-peltatin as the Bioactive Compound: Further isolation and analysis revealed that β-peltatin, a small molecule extracted from BTW, is the dominant bioactive component driving PD's anti-cancer action.
  • Mechanism of Action: Both PD and β-peltatin work by inducing cell cycle arrest at the G2/M phase and triggering apoptosis in PAC cells. This is mediated by the downregulation of G2/M phase regulators (like p-CDC25C and p-CDK1) and the upregulation of cell cycle progression markers (like Cyclin B1 and p-Histone H3), along with the activation of apoptotic pathways (cleaved PARP, Caspase 3, Caspase 9) and downregulation of anti-apoptotic proteins (Bcl-2).
  • Superior Safety Profile: β-peltatin demonstrated a significantly better safety profile compared to its isomer, podophyllotoxin, which has been limited in clinical use due to severe toxicity. β-peltatin showed higher efficacy and lower mortality in animal models.

Key Results

  • PD significantly inhibited PAC cell proliferation and induced apoptosis.
  • Pulsatillae chinensis (BTW) was found to be the most potent anti-PAC herb within PD.
  • β-peltatin was identified as a highly potent cytotoxic compound with IC50 values in the low nanomolar range (e.g., ~2 nM in MIA PaCa-2 cells).
  • β-peltatin treatment led to a significant accumulation of cells in the G2/M phase and increased apoptosis.
  • In vivo studies showed that β-peltatin significantly suppressed tumor growth in a xenograft model without causing significant toxicity to major organs or body weight.
  • β-peltatin demonstrated a higher tumor suppressive effect and a lower mortality rate compared to podophyllotoxin in mice.

Limitations and Future Work

  • Mechanistic Depth: While the study identified key proteins involved in G2/M arrest and apoptosis, further in-depth mechanistic studies are suggested to fully elucidate the pathways and identify potential drug targets.
  • Patient Selection and Optimization: The authors suggest that further research is needed to facilitate suitable patient selection and optimize treatment response for β-peltatin.
  • Innovative Technologies: The paper proposes the use of advanced technologies like Omics, PROTAC, and GST pull-down to explore more detailed mechanisms and identify potential targets of PD in PAC cells.
  • Clinical Translation: The promising safety profile of β-peltatin, in contrast to podophyllotoxin, is highlighted as critical for its potential development towards clinical application.

Summary updated

Abstract

Our results demonstrate that Pulsatillae chinensis and particularly its bioactive ingredient β-peltatin suppress PAC by triggering cell cycle arrest at G2/M phase and apoptosis.
BibTeX
@inproceedings{wu2023pulsatilla,
  author = {Rong Wu and Zhichao Xi and Mengfan Liu and Hangui Ren and Rongchen Dai and Xue Jiang and Wan Najbah Nik Nabil and Yalin Wang and Jiling Feng and Qiong Chai and Qihan Dong and Hong‐Xi Xu},
  title = {{Pulsatilla Decoction and its bioactive component β-peltatin induce G2/M cell cycle arrest and apoptosis in pancreatic cancer}},
  booktitle = {Chinese},
  year = {2023},
  doi = {10.1186/s13020-023-00774-0},
}
Figure